TERMIUM Plus^®

Fiche 1,  Justifications,  Anglais

Record number: 1, Textual support number: 1 CONT

Body roundness index (BRI) is [an] anthropometric index developed to predict both body fat and the percentage of visceral adipose tissue.  2, fiche 1, Anglais, - body%20roundness%20index

Record number: 1, Textual support number: 2 CONT

Body roundness index(BRI) might be a more accurate measurement than body mass index(BMI) for predicting weight-related health risks... BMI has long been the standard to classify a person's body weight as too low, normal, overweight, or obese. While BMI often reflects a person's body fat amount, it doesn’t account for fat distribution or the amount of muscle mass.... BRI addresses these shortcomings by focusing on a person's height, waist size, and hip size. By taking weight out of the equation, BRI provides a better indicator of how much belly fat(visceral fat) surrounds the organs inside the abdomen. High amounts of belly fat are linked to high blood pressure, heart disease, diabetes, and some cancers.  3, fiche 1, Anglais, - body%20roundness%20index

Fiche 1,  Justifications,  Français

Fiche 1,  Justifications,  Espagnol

Fiche 2,  Justifications,  Anglais

Record number: 2, Textual support number: 1 CONT

The fetus showed abnormal facial features with a flat nose, a persistently open mouth in a fish-mouth-like configuration with protruding tongue, bilateral flattened rudimentary external ears, and hypoechoic mass lesions in front of each globe. Three-dimensional surface rendered images of the fetal face showed cracks in the skin. The fingers and toes were seen to be persistently in flexed position. No associated visceral anomaly was seen and rest of the ultrasound examination was normal.  3, fiche 2, Anglais, - three%2Ddimensional%20surface%20rendered%20image

Fiche 2,  Justifications,  Français

Record number: 2, Textual support number: 1 OBS

En scanographie moderne (mais aussi en échographie et en IRM [imagerie par résonance magnétique]), [il est possible] de montrer la surface des structures observées en créant l'impression d'une représentation en trois dimensions.  2, fiche 2, Français, - repr%C3%A9sentation%20tridimensionnelle%20de%20surface

Fiche 2,  Justifications,  Espagnol

Fiche 3,  Justifications,  Anglais

Record number: 3, Textual support number: 1 DEF

A lipase inhibitor that aids weight loss by reversibly binding to the active center of the enzyme lipase, preventing the digestion and absorption of some dietary fats.  3, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Record number: 3, Textual support number: 1 CONT

Orlistat, when used in conjunction with a mildly hypocaloric diet, is indicated for obesity management including weight loss and weight maintenance.... Orlistat is indicated for obese patients with a BMI [body mass index] [greater than or equal to] 30 kg/m² or a BMI [greater than or equal to] 27 kg/m² in the presence of other risk factors(e. g. hypertension, type 2 diabetes, dyslipidemia, excess visceral fat).  4, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Record number: 3, Textual support number: 1 OBS

[(2S)-1-[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]tridecan-2-yl] N-formyl-L-leucinate: The capital letter "N-" must be italicized; The letter "L-" is a small capital; form recommended by the IUPAC (International Union of Pure and Applied Chemistry) for the systematic name corresponding to the CAS number indicated on the present record.  1, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Record number: 3, Textual support number: 2 OBS

orlistat: international nonproprietary name (INN).  1, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Record number: 3, Textual support number: 3 OBS

Xenical (Roche): Name under which the active ingredient is sold.  5, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Record number: 3, Textual support number: 4 OBS

Chemical formula: C₂₉H₅₃NO₅  5, fiche 3, Anglais, - %5B%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Doxetan%2D2%2Dyl%5Dtridecan%2D2%2Dyl%5D%20N%2Dformyl%2DL%2Dleucinate

Fiche 3,  Justifications,  Français

Record number: 3, Textual support number: 1 DEF

Médicament qui agit contre l'obésité en inhibant, dans la lumière du tube digestif, l'activité de la lipase pancréatique, diminuant ainsi l'absorption des graisses.  3, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Record number: 3, Textual support number: 1 CONT

L'orlistat (Xenical). Ce médicament a pour effet d'entraver l'enzyme responsable de l'absorption des graisses dans le tube digestif. Il empêche ainsi l'absorption d'environ 30 % des graisses alimentaires (triglycérides), ce qui équivaut à une réduction calorique de 150 à 200 calories/jour pour un apport journalier de 1800 calories. Les graisses non absorbées sont éliminées dans les selles.  4, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Record number: 3, Textual support number: 1 OBS

N-formyl-L-leucinate de (2S)-1-[(2S,3S)-3-hexyl-4-oxo-oxétan-2-yl]tridécan-2-yle : La lettre majuscule «N-» s'écrit en italique; la lettre «L-» est une petite majuscule; forme recommandée par l'UICPA (Union internationale de chimie pure et appliquée) pour le nom systématique correspondant au numéro CAS indiqué sur la présente fiche.  1, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Record number: 3, Textual support number: 2 OBS

orlistat: dénomination commune internationale (DCI).  1, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Record number: 3, Textual support number: 3 OBS

Xenical (Roche) : Nom sous lequel le principe actif est commercialisé.  5, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Record number: 3, Textual support number: 4 OBS

Formule chimique : C₂₉H₅₃NO₅  5, fiche 3, Français, - N%2Dformyl%2DL%2Dleucinate%20de%20%282S%29%2D1%2D%5B%282S%2C3S%29%2D3%2Dhexyl%2D4%2Doxo%2Dox%C3%A9tan%2D2%2Dyl%5Dtrid%C3%A9can%2D2%2Dyle

Fiche 3,  Justifications,  Espagnol

Fiche 4,  Justifications,  Anglais

Record number: 4, Textual support number: 1 OBS

"Flower" suggested that the camerae [of a nautiloid] were lined with tissue which he proposed to call "cameral mantle". This was presumed to develop from the mantle enveloping the posterior part of the visceral mass, when the animal was moving into position to build the next following septum.  1, fiche 4, Anglais, - cameral%20mantle

Fiche 4,  Justifications,  Français

Record number: 4, Textual support number: 1 OBS

Flower (1939) distingue, dans le manteau [d'un Nautile], plusieurs régions sécrétrices: (...) le manteau "caméral" [est] responsable des dépôts caméraux.  1, fiche 4, Français, - manteau%20cam%C3%A9ral

Fiche 4,  Justifications,  Espagnol